Coenen Carolin, Liedtke Stefanie, Kogler Gesine
Institute of Transplantation Diagnostics and Cell Therapeutics, Heinrich-Heine-University Medical Center, 40225, Düsseldorf, Germany.
PLoS One. 2015 Oct 20;10(10):e0141070. doi: 10.1371/journal.pone.0141070. eCollection 2015.
The amplification of RNA is becoming increasingly important, as often only limited amounts of cells are available for gene expression analysis. In this study, the gene expression profile of the 39 human homeobox (HOX) genes was analyzed in bone marrow-derived multipotent stromal cells (BM-MSCs) by reverse transcription (RT-) and quantitative polymerase chain reaction (qPCR). For further unlimited gene expression analysis, Whole Transcriptome Amplification (WTA) was used to amplify RNA from human BM-MSCs. However, WTA led to biased RT- and qPCR results, and even non-detectability of HOX transcripts compared to non-amplified BM-MSC samples which instead revealed transcription. It is important to note that the same RNA of the respective human BM-MSC line was used for normal cDNA synthesis by standard reverse transcription (non-amplified RT samples) and for cDNA synthesis by WTA (amplified WTA samples). On this account, the different RT- and qPCR results were unexpected applying WTA. The significantly reduced detection of HOX transcripts after WTA has been demonstrated for numerous BM-MSC lines (n = 26) by RT-PCR analysis. Furthermore, undetectable HOX transcripts meaning HOX transcripts of human BM-MSCs that were detected after normal cDNA synthesis, but were no longer detectable after WTA, were consistently observed by qPCR analysis. Finally, qPCR experiments revealed a possible explanation for the differences between amplified and non-amplified BM-MSC samples: an inverse correlation between the biased qPCR results and the low expression level of the respective HOX gene. The PCR analysis of high-copy transcripts like GAPDH or RPL13A revealed unchanged qPCR results after WTA compared to corresponding non-amplified BM-MSC samples. In contrast, WTA led to biased qPCR results for medium-copy HOX transcripts, and even non-detectability of low-copy HOX transcripts of human BM-MSCs resulting in false negative RT- and qPCR data applying WTA.
由于通常只有有限数量的细胞可用于基因表达分析,RNA的扩增变得越来越重要。在本研究中,通过逆转录(RT-)和定量聚合酶链反应(qPCR)分析了骨髓来源的多能基质细胞(BM-MSC)中39个人类同源框(HOX)基因的基因表达谱。为了进行进一步的无限制基因表达分析,使用全转录组扩增(WTA)来扩增来自人类BM-MSC的RNA。然而,与未扩增的BM-MSC样本相比,WTA导致RT-和qPCR结果出现偏差,甚至无法检测到HOX转录本,而未扩增的样本却显示出转录情况。需要注意的是,各自人类BM-MSC系的相同RNA用于通过标准逆转录进行正常cDNA合成(未扩增的RT样本)以及通过WTA进行cDNA合成(扩增的WTA样本)。因此,应用WTA时出现不同的RT-和qPCR结果是出乎意料的。通过RT-PCR分析已证明,对于众多BM-MSC系(n = 26),WTA后HOX转录本的检测显著减少。此外,通过qPCR分析一致观察到,未检测到的HOX转录本(即人类BM-MSC的HOX转录本在正常cDNA合成后可检测到,但在WTA后不再可检测到)。最后,qPCR实验揭示了扩增和未扩增的BM-MSC样本之间差异的一个可能解释:qPCR结果偏差与相应HOX基因低表达水平之间呈负相关。与相应的未扩增BM-MSC样本相比,对高拷贝转录本如GAPDH或RPL13A的PCR分析显示WTA后qPCR结果未改变。相反,WTA导致中等拷贝HOX转录本的qPCR结果出现偏差,甚至导致人类BM-MSC低拷贝HOX转录本无法检测到,从而在应用WTA时产生假阴性RT-和qPCR数据。